Practice
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
Amer Sports $1.37 billion IPO
We advised Amer Sports on its IPO and NYSE listing
Nextracker spinoff from Flex
We advised Nextracker on its spinoff
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Virgin Acquisition Corp. II $1.5 billion combination with Grove Collaborative
We are advising Virgin Acquisition Corp. II on the transaction
Ingenovis Health acquisition of HealthCare Support Staffing
We are advising Cornell Capital, Trilantic Partners and Ingenovis Health on the transaction
Hexion Holdings $1.2 billion sale of its epoxy businesses to Westlake Chemical
We are advising Hexion on the transaction
Privia Health $174 million secondary offering
We advised Privia on its SEC-registered offering of stock
Crescera Capital Acquisition $201 million IPO
We advised Crescera Capital Acquisition, a SPAC, on its IPO and Nasdaq listing
Ankura Consulting Group investment from HPS Investment Partners
We are advising Ankura on the transaction
Novo Nordisk $3.3 billion acquisition of Dicerna Pharmaceuticals
We are advising Novo Nordisk on the transaction
Ankura Consulting Group acquisition of McLarty Associates
We are advising Ankura on the transaction
Alpha Capital Acquisition merger with Semantix
We are advising Alpha Capital Acquisition on the transaction
BDT Capital Partners acquires a majority interest in MJH Life Sciences
We are advising BDT Capital Partners on the transaction